4/19/2024:
https://investorshangout.com/post/view?id=6686199
03/25/2025:
https://investorshangout.com/post/view?id=6751885
4/16/2025:
https://investorshangout.com/post/view?id=6755522
09/12/2025
My69z
Google says:
Diagnostic and Laboratory Disposables:
This is the most lucrative segment within the medical disposables market, showing the fastest growth.
Cytodyn, find a way to secure a % of Assay test fees, from Creativ-bio -- with a 1st Right Refusal
___
08/27/2025
My69z
Screening & Early Detection: LifeTracDx® may detect cancer in patients with no prior history, across all stages and in multiple organs.
( LL+Creativ+ICI combo could be prophylactic )
Real-time insights into cancer aggressiveness: LifeTracDx® may determine the aggressiveness of the patient’s cancer at any time.
(There's our CRC real-time viewing)
___
9/25/2025
My69z
Creatv Bio has analyzed patient samples from over 30 types of cancer, including both solid tumors and blood cancers.
( as of Aug. video we're testing PD-L1 of 9 cancers )
* The team also aims to secure insurance and Medicare reimbursement,
* Our ultimate goal is to get the LifeTracDx® information out to oncologists so they can provide better treatment of their patients,”
( I've wondered if Creativ seeking FDA approval was an aspect of seemingly our trials being delayed. The Aug video was a floodgate of PD-L1 observing )
Never really looked @ Creativ until now. Unmatched betterment for humanity collaboration:
LL+Creativ+ICI
https://theceoviews.com/creatvbio-revolutioni...agnostics/
_____
Nov. 24th, 2025.
Add to the Creativ Micro now discussions across boards. It's exactly what Dr. Adam's addressed in October:
Immunogenicity Prediction & Control
https://stocktwits.com/my69z/message/637334800
___
Saying it again today, Cytodyn should score a % equity of Creativ assay sales.
Especially if the FDA ok's Cytodyn trials as route for Creativ's LifeTracDx & Sieve moving beyond current lab/testing, to FDA approved tests, for trial Approvals
3
